Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Dyne Therapeutics Inc.

An update from Dynagreen Environmental Protection Group Co., Ltd. Class H ( ($HK:1330) ) is now available. Dynagreen Environmental Protection Group...

Dynagreen Launches First Grant Under Restricted A Share Incentive Scheme

Dynagreen Lowers Conversion Price on A Share Convertible Bonds After Incentive Share Issue

Dye & Durham ( ($TSE:DND) ) has provided an announcement. Dye & Durham has disclosed a further delay in filing its audited financial statements for...

Dye & Durham Delays 2025 Financial Filings and Seeks Court Approval to Postpone Shareholders’ Meeting

The latest announcement is out from Dye & Durham ( ($TSE:DND) ). Dye & Durham Limited said Canada’s Commissioner of Competition has discontinued a ...

Dye & Durham Cleared as Competition Bureau Drops Inquiry

Dyne Therapeutics ( ($DYN) ) has provided an update. On December 22, 2025, Dyne Therapeutics, Inc.’s board of directors elected Vikram Karnani as a...

Dyne Therapeutics Appoints Vikram Karnani to Board

Dye & Durham ( ($TSE:DND) ) has shared an update. Dye & Durham has formally initiated a strategic sale process to explore options for restructuring...

Dye & Durham Launches Strategic Sale Process and Amends Credit Agreement

Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Dyne Therapeutics yesterday and set a price target of $36.00. The company’s shares ...

Dyne Therapeutics (DYN) Gets a Buy from Stifel Nicolaus

Dye & Durham ( ($TSE:DND) ) has provided an update. Dye & Durham Limited announced that the Ontario Securities Commission has issued a failure-to-f...

Dye & Durham Faces Cease Trade Order Over Filing Delays

Dye & Durham ( ($TSE:DND) ) has provided an update. Dye & Durham Limited announced the adjournment of a court hearing regarding its application for...

Dye & Durham Court Hearing Adjourned for Shareholder Opposition

An announcement from Dyne Therapeutics ( ($DYN) ) is now available. On December 9, 2025, Dyne Therapeutics announced the pricing of an upsized unde...

Dyne Therapeutics Announces Upsized Public Offering

Dye & Durham ( ($TSE:DND) ) has issued an announcement. Dye & Durham Limited has announced an update regarding its management cease trade order (MC...

Dye & Durham Faces Financial Filing Delays Amid MCTO Extension

An update from Dye & Durham ( ($TSE:DND) ) is now available. Dye & Durham Limited has announced the filing of its management information circular f...

Dye & Durham Seeks Court Relief for Shareholder Meeting Amid Audit Delays

The latest update is out from Dyne Therapeutics ( ($DYN) ). On December 8, 2025, Dyne Therapeutics announced positive topline results from its Phas...

Dyne Therapeutics Reports Positive Phase 1/2 Trial Results

Dye & Durham ( ($TSE:DND) ) has issued an update. Dye & Durham Limited has announced significant changes to its Board of Directors following a Sett...

Dye & Durham Announces Board Restructuring and Strategic Alignment with OneMove

Dynagreen Environmental Protection Group Co., Ltd. Class H ( ($HK:1330) ) has issued an update. Dynagreen Environmental Protection Group Co., Ltd. ...

Dynagreen Adjusts Restricted Share Incentive Scheme and Completes Dividend Distributions

Dynagreen Environmental Protection Group Co., Ltd. Class H ( ($HK:1330) ) has issued an announcement. Dynagreen Environmental Protection Group Co.,...

Dynagreen Environmental Protection Group Enhances Audit and Risk Management Committee Rules

The latest update is out from DynaResource ( ($DYNR) ). On November 20, 2025, DynaResource, a company involved in the mining industry, made signifi...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DYN	$20.35	-0.29%	876.84K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DYN	$20.35	-0.3%	876.84K
3
4
5
6

DYN

DYN

Get Dyne Therapeutics Inc. Data in Excel

Get Dyne Therapeutics Inc. Data in Excel